The Experts in Animal Health

Brakke Viewpoint August 12, 2022

We should not give up on developing a MLV vaccine for ASF. In recent meetings with R&D leaders of domestic and international animal health companies in China, the topic of a modified live virus (MLV) vaccine for African Swine Fever (ASF) was often discussed. Most...

Brakke Viewpoint August 5, 2022

In this space last week, Bob Jones published a thought-provoking Viewpoint on the topic of FDA Animal Drug User Fees. He asked if readers felt that the User Fee amounts are reasonable. Not surprisingly, 57% said the fees are too high. I recently read “Flying...

Brakke Viewpoint July 29, 2022

Do high FDA Animal Drug Users Fees slow innovation in animal drugs? Each year the FDA ADUFA/AGDUFA fees change due to inflation, workload, and prior year excesses or shortfalls in collections.  Starting in October, New Animal Drug Applications will require a $659,364...

Brakke Viewpoint July 22, 2022

In recent weeks I have been visiting corporate offices and cannot help but notice how empty some of them are. As we recover from the pandemic and are now in the endemic part of the story, will there ever be a return to the days when people went to offices to work and...

Brakke Viewpoint July 15, 2022

We have had a few consulting projects lately where we reviewed how the top global animal health companies have grown.  So when I saw an article from McKinsey entitled, “Choosing to grow: The leader’s blueprint”, I was curious to see what the world’s largest consulting...

Brakke Viewpoint July 8, 2022

The financial markets have taken a beating thus far in 2022.  The Dow Jones Industrial Average has declined -14%, while the S&P 500 Index is down -18% YTD.  Perhaps indicative of the animal health segment, PAWZ, the Petcare ETF that tracks the animal health...

Thank you